Publications of M. Labeur
All genres
Journal Article (26)
21.
Journal Article
147 (9), pp. 4438 - 4444 (2006)
Retinoic acid as a novel medical therapy for Cushing's disease in dogs. Endocrinology 22.
Journal Article
147 (1), pp. 247 - 256 (2006)
Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action. Endocrinology 23.
Journal Article
563 (1-3), pp. 229 - 233 (2004)
Nur77 induction and activation are necessary for interleukin-1 stimulation of proopiomelanocortin in AtT-20 corticotrophs. FEBS Letters 24.
Journal Article
4, pp. 335 - 342 (2004)
New perspectives in the treatment of Cushing`s Syndrome. Current Drug Targets - Immune, Endocrine & Metabolic Disorders 25.
Journal Article
15, pp. 241 - 249 (1995)
TRH receptor on immune cells: in vitro and in vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis. Journal of Clinical Immunology 26.
Journal Article
134, pp. 672 - 677 (1994)
Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin. Endocrinology Book Chapter (4)
27.
Book Chapter
Arzt, E.; Bronstein, M.; Guitelman, M.). Karger, Basel (2010)
Cytokines and Genes in Pituitary Tumorigenesis: RSUME Role in Cell Biology. In: Pituitary Today II: New Molecular, Physiological and Clinical Aspects, pp. 1 - 6 (Eds. 28.
Book Chapter
Arzt, E.; Bronstein, M.; Guitelman, M.). Karger, Basel (2010)
Novel Medical Therapies for Pituitary Tumors. In: Pituitary Today II: New Molecular, Physiological and Clinical Aspects, pp. 158 - 164 (Eds. 29.
Book Chapter
Arzt, E.; Bronstein, M.; Guitelman, M.). KARGER, BASEL (2006)
Bone morphogenetic protein-4 control of pituitary pathophysiology. In: PITUITARY TODAY: MOLECULAR, PHYSIOLOGICAL AND CLINICAL ASPECTS, pp. 22 - 31 (Eds. 30.
Book Chapter
Arzt, E.; Bronstein, M.; Guitelman, M.). KARGER, BASEL (2006)
New aspects in the diagnosis and treatment of Cushing disease. In: PITUITARY TODAY: MOLECULAR, PHYSIOLOGICAL AND CLINICAL ASPECTS, pp. 169 - 178 (Eds.